In patients with secondary Hemophagocytic LymphoHistiocytosis (sHLH), including Macrophage Activation Syndrome (MAS), flow cytometry can reveal an increased frequency of CD4dimCD8+ T cells, expressing high levels of activation markers CD38 and HLA-DR. This evidence concerns the gene CD38 and macrophage activation syndrome.